GLP-1 receptor agonist
Liraglutide companies
Answer
Public registers name 10 licence holders, 25 bulk ingredient labelers, 13 US labelers, 205 trial sponsors, 5 companies with an FDA warning letter and 2 recalling firms for Liraglutide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
MARKETING AUTHORISATION HOLDER
10 companies
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| ADALVO LIMITED | LIRAGLUTIDE ADALVO 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 51289/0011, Authorised Regulator MHRA |
|---|---|
| BIOCON PHARMA UK LIMITED | DIAVORIN 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 50674/0021, Authorised Regulator MHRA LOBEZYL 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 50674/0022, Authorised Regulator MHRA |
| CIPLA (EU) LIMITED | PINSUBET 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 36390/0416, Authorised Regulator MHRA PLAOBES 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 36390/0417, Authorised Regulator MHRA |
| DR REDDY'S LABORATORIES (UK) LIMITED | LANITY 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 08553/0866, Authorised Regulator MHRA LIRAGLUTIDE DR. REDDY'S 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 08553/0871, Authorised Regulator MHRA |
| Novo Nordisk A/S | Saxenda (EMEA/H/C/003780), Authorised Regulator EMA Victoza (EMEA/H/C/001026), Authorised Regulator EMA Xultophy (EMEA/H/C/002647), Authorised Regulator EMA |
| NOVO NORDISK AS | SAXENDA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0409, Authorised Regulator MHRA |
| NOVO NORDISK CANADA INC | SAXENDA (DIN 02437899), Marketed Regulator Health Canada VICTOZA (DIN 02351064), Marketed Regulator Health Canada |
| STADA Arzneimittel AG | Ablymico (EMEA/H/C/006620), Authorised Regulator EMA Liraglutide STADA (EMEA/H/C/006615), Authorised Regulator EMA |
| SUN PHARMA UK LIMITED | DIAVIC 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 14894/0790, Authorised Regulator MHRA LIGOBESY 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 14894/0797, Authorised Regulator MHRA |
| ZENTIVA PHARMA UK LIMITED | LIRAGLUTIDE ZENTIVA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 17780/1224, Authorised Regulator MHRA NEVOLAT 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 17780/1252, Authorised Regulator MHRA |
BULK INGREDIENT LABELER
25 companies
Lists the bulk active ingredient with FDA (NDC directory).
| Aurobindo Pharma Limited | Liraglutide, BULK INGREDIENT Regulator openFDA |
|---|---|
| Bachem Americas, Inc. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Biocon Limited | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Chengdu Shengnuo Biopharm Co. Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Darmerica, LLC | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Dr.Reddy's laboratories Limited | Liraglutide, BULK INGREDIENT Regulator openFDA |
| ETERNAL WEALTH(CHINA)LIMITED | Liraglutide, BULK INGREDIENT Regulator openFDA |
| FRESENIUS KABI IPSUM SRL | LIRAGLUTIDE, BULK INGREDIENT Regulator openFDA |
| Fujian Genohope Biotech Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Hubei JXBio Pharmaceutical Co.,Ltd | liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Hybio Pharmaceutical Co., Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Liraglutide, BULK INGREDIENT Regulator openFDA |
| MSN Life Sciences Private Limited | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Nanjing Xingyin Pharmaceutical Group Co.,Ltd | Liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| NOMIDA LLC | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Novo Nordisk A/S | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Polypeptide Laboratories Inc | LIRAGLUTIDE, BULK INGREDIENT Regulator openFDA |
| Qingdao Biopeptek Co., Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| ScinoPharm Taiwan Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Shanghai Ambiopharm, Inc | Liraglutide, BULK INGREDIENT Regulator openFDA |
| SHILPA PHARMA LIFESCIENCES LIMITED | Liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Sinopep-Allsino Biopharmaceutical Co., Ltd. | Liraglutide, BULK INGREDIENT Regulator openFDA LIRAGLUTIDE, BULK INGREDIENT Regulator openFDA Liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| SUN PHARMACEUTICAL INDUSTRIES INC | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Tonghua Dongbao Pharmaceutical Co., Ltd | Liraglutide, BULK INGREDIENT Regulator openFDA |
| Zhejiang Peptites Biotech Co., Ltd | Liraglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
US LABELER
13 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| A-S Medication Solutions | Liraglutide, NDA AUTHORIZED GENERIC Regulator openFDA Saxenda, NDA Regulator openFDA Victoza, NDA Regulator openFDA |
|---|---|
| Biocon Pharma Inc. | Liraglutide, ANDA Regulator openFDA |
| Cipla USA, Inc. | liraglutide, ANDA Regulator openFDA LIRAGLUTIDE, ANDA Regulator openFDA |
| Hikma Pharmaceuticals USA Inc. | Liraglutide, ANDA Regulator openFDA |
| Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Liraglutide, ANDA Regulator openFDA |
| Lupin Pharmaceuticals Inc. | Liraglutide, ANDA Regulator openFDA |
| Meitheal Pharmaceuticals, Inc | Liraglutide, ANDA Regulator openFDA |
| NorthStar Rx LLC | Liraglutide, ANDA Regulator openFDA |
| Novo Nordisk | Victoza, NDA Regulator openFDA |
| Novo Nordisk Pharmaceutical Industries, LP | Saxenda, NDA Regulator openFDA |
| Orbicular Pharmaceutical Technologies Private Limited | liraglutide, ANDA Regulator openFDA LIRAGLUTIDE, ANDA Regulator openFDA |
| Teva Pharmaceuticals USA, Inc | Liraglutide, NDA AUTHORIZED GENERIC Regulator openFDA |
| Teva Pharmaceuticals, Inc. | Liraglutide, ANDA Regulator openFDA |
TRIAL SPONSOR
205 companies
Sponsors registered clinical trials of the peptide.
| Novo Nordisk A/S | 1 registered trial Trial register EU CTIS 139 registered trials Trial register ClinicalTrials.gov |
|---|---|
| University at Buffalo | 8 registered trials Trial register ClinicalTrials.gov |
| University Medical Centre Ljubljana | 8 registered trials Trial register ClinicalTrials.gov |
| Eli Lilly & Company | 7 registered trials Trial register ClinicalTrials.gov |
| Hvidovre University Hospital | 6 registered trials Trial register ClinicalTrials.gov |
| Sanofi | 5 registered trials Trial register ClinicalTrials.gov |
| Xiangya Hospital of Central South University | 5 registered trials Trial register ClinicalTrials.gov |
| Henrik Gudbergsen | 4 registered trials Trial register ClinicalTrials.gov |
| Merck Sharp & Dohme LLC | 4 registered trials Trial register ClinicalTrials.gov |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 4 registered trials Trial register ClinicalTrials.gov |
| University of Miami | 4 registered trials Trial register ClinicalTrials.gov |
| AstraZeneca | 3 registered trials Trial register ClinicalTrials.gov |
| Brigham and Women's Hospital | 3 registered trials Trial register ClinicalTrials.gov |
| Centre Hospitalier Universitaire Dijon | 3 registered trials Trial register ClinicalTrials.gov |
| GlaxoSmithKline | 3 registered trials Trial register ClinicalTrials.gov |
| Mayo Clinic | 3 registered trials Trial register ClinicalTrials.gov |
| Stanford University | 3 registered trials Trial register ClinicalTrials.gov |
| Steno Diabetes Center Copenhagen | 3 registered trials Trial register ClinicalTrials.gov |
| Third Military Medical University | 3 registered trials Trial register ClinicalTrials.gov |
| University Health Network, Toronto | 3 registered trials Trial register ClinicalTrials.gov |
| University of Aarhus | 3 registered trials Trial register ClinicalTrials.gov |
| Amsterdam UMC, location VUmc | 2 registered trials Trial register ClinicalTrials.gov |
| Anna Cruceta | 2 registered trials Trial register ClinicalTrials.gov |
| Beth Israel Deaconess Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Bo Feldt-Rasmussen | 2 registered trials Trial register ClinicalTrials.gov |
| Boehringer Ingelheim | 2 registered trials Trial register ClinicalTrials.gov |
| Cedars-Sinai Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Chen Wei Ren, MD | 2 registered trials Trial register ClinicalTrials.gov |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 registered trials Trial register ClinicalTrials.gov |
| Chinese PLA General Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Imperial College London | 2 registered trials Trial register ClinicalTrials.gov |
| Leiden University Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Medical University of Graz | 2 registered trials Trial register ClinicalTrials.gov |
| Medical University Of Vienna | 2 registered trials Trial register ClinicalTrials.gov |
| Mount Sinai Hospital, Canada | 2 registered trials Trial register ClinicalTrials.gov |
| National and Kapodistrian University of Athens | 2 registered trials Trial register ClinicalTrials.gov |
| Novartis Pharmaceuticals | 2 registered trials Trial register ClinicalTrials.gov |
| Second Xiangya Hospital of Central South University | 2 registered trials Trial register ClinicalTrials.gov |
| Sun Yat-sen University | 2 registered trials Trial register ClinicalTrials.gov |
| Temple University | 2 registered trials Trial register ClinicalTrials.gov |
Showing 40 of 205.
WARNING LETTER RECIPIENT
5 companies
Received an FDA warning letter naming the peptide.
| Eli Lilly & Company | False & Misleading Claims/Misbranded, 2025-09-09 Regulator FDA warning letters |
|---|---|
| Kare Solutions, LLC dba Zappy | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Levity Inc. dba Levity | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Momentum Health 360 dba Momentum Health | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Novo Nordisk Inc | False & Misleading Claims/Misbranded, 2025-09-09 Regulator FDA warning letters Postmarketing Adverse Drug Experience Reporting Requirements, 2026-03-05 Regulator FDA warning letters |
RECALLING FIRM
2 companies
Recalled a product naming the peptide (FDA enforcement report).
| Lupin Pharmaceuticals Inc. | Class II recall, Ongoing, 2026-05-27 Regulator openFDA |
|---|---|
| Novo Nordisk Inc | Class II recall, Terminated, 2021-04-21 Regulator openFDA |
Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.